[JPI Seminar] Ministry of Health, Labour and Welfare "Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials" to be held on Thursday, April 9th
株式会社日本計画研究所（JPI）は、「ビジネスデザインに基づく人材育成と組織変革」と題したセミナーを4月16日(木)に開催する。内容の詳細は本文に記載がなく不明である。
📋 Article Processing Timeline
- 📰 Published: March 28, 2026 at 17:11
- 🔍 Collected: March 28, 2026 at 21:59 (4h 48m after Published)
- 🤖 AI Analyzed: April 6, 2026 at 14:15 (208h 15m after Collected)
JPI (Japan Planning Institute) will hold a seminar inviting Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare, to explain in detail about building a drug discovery ecosystem and measures to promote clinical trials.
[Details and Registration]
https://www.jpi.co.jp/seminar/17693
[Title]
The Deepening "Drug Loss" Problem and Strengthening Japan's Drug Discovery Capabilities
Ministry of Health, Labour and Welfare: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials
~ Regulatory Harmonization and Concrete Measures for the Rapid Delivery of the Latest Medicines ~
[Date and Time]
Thursday, April 09, 2026, 09:30 - 11:30
* Applications for archive streaming will be accepted even after the seminar has ended.
[Lecturer]
Mr. Yasuhiro Araki
Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare
[Lecture Overview]
In recent years, the problem of "drug loss," where medicines approved in Europe and the United States are not developed in Japan, has become apparent, pointing out the risk that innovative medicines may not be provided in Japan.
In response to this, the public and private sectors in Japan are working together to advance discussions aimed at (1) strengthening Japan's drug discovery capabilities, (2) rapidly delivering the latest medicines to the public, and (3) building a social system where the cycle of investment and innovation is sustained.
In this lecture, we will provide an overview of the government's efforts to build a drug discovery ecosystem in Japan, as well as detail the current status of clinical trials conducted by the Ministry of Health, Labour and Welfare and various measures to promote them.
[Lecture Items]
1. The current status of drug loss in Japan
2. Policies for building a drug discovery ecosystem in Japan
3. Current status and challenges regarding clinical trials in Japan
4. Initiatives by the Ministry of Health, Labour and Welfare to promote clinical trials
5. Related Q&A
6. Business card exchange and networking session
In addition to direct dialogue and Q&A with lecturers who are usually difficult to meet, this is a valuable opportunity unique to JPI seminars to gain information useful for practical business and opportunities for new collaboration through networking among attendees across industries and sectors.
[Format]
- On-site participation (Archive streaming is not included)
- Live streaming participation (Archive streaming is not included)
- Archive streaming participation
* Those participating on-site or via live streaming can add archive streaming at a special price of 18,500 yen (tax included).
[Tuition Fee]
1 person: 37,320 yen (tax included)
Bonus: For each attendee, one person from the same corporation can accompany them for free (registration required)
* For those belonging to local governments: up to 2 people for 11,000 yen (tax included / limited to on-site and live streaming)
[Details and Registration]
https://www.jpi.co.jp/seminar/17693
- After the seminar ends, we also accept questions for the lecturer and can act as an intermediary.
- It is highly useful for building human networks among lecturers and attendees, and for creating new businesses.
- Applications for archive streaming will be accepted even after the seminar has ended.
[Contact]
Japan Planning Institute Inc.
Kowa Hiroo Bldg., 5-2-32 Minamiazabu, Minato-ku, Tokyo 106-0047
TEL. 03-5793-9761
FAX. 03-5793-9767
URL: https://www.jpi.co.jp
[About JPI (Japan Planning Institute)]
As a "bridge of knowledge connecting politics, bureaucracy, and the private sector," we support the widespread application of national policies and national projects, and have been providing information useful for the business execution of executives and senior managers aiming to create national knowledge in the form of realistic seminars limited to attendees for half a century.
[Details and Registration]
https://www.jpi.co.jp/seminar/17693
[Title]
The Deepening "Drug Loss" Problem and Strengthening Japan's Drug Discovery Capabilities
Ministry of Health, Labour and Welfare: Building a Drug Discovery Ecosystem and Measures to Promote Clinical Trials
~ Regulatory Harmonization and Concrete Measures for the Rapid Delivery of the Latest Medicines ~
[Date and Time]
Thursday, April 09, 2026, 09:30 - 11:30
* Applications for archive streaming will be accepted even after the seminar has ended.
[Lecturer]
Mr. Yasuhiro Araki
Director of the Clinical Trial Promotion Office, Research and Development Policy Division, Health Policy Bureau, Ministry of Health, Labour and Welfare
[Lecture Overview]
In recent years, the problem of "drug loss," where medicines approved in Europe and the United States are not developed in Japan, has become apparent, pointing out the risk that innovative medicines may not be provided in Japan.
In response to this, the public and private sectors in Japan are working together to advance discussions aimed at (1) strengthening Japan's drug discovery capabilities, (2) rapidly delivering the latest medicines to the public, and (3) building a social system where the cycle of investment and innovation is sustained.
In this lecture, we will provide an overview of the government's efforts to build a drug discovery ecosystem in Japan, as well as detail the current status of clinical trials conducted by the Ministry of Health, Labour and Welfare and various measures to promote them.
[Lecture Items]
1. The current status of drug loss in Japan
2. Policies for building a drug discovery ecosystem in Japan
3. Current status and challenges regarding clinical trials in Japan
4. Initiatives by the Ministry of Health, Labour and Welfare to promote clinical trials
5. Related Q&A
6. Business card exchange and networking session
In addition to direct dialogue and Q&A with lecturers who are usually difficult to meet, this is a valuable opportunity unique to JPI seminars to gain information useful for practical business and opportunities for new collaboration through networking among attendees across industries and sectors.
[Format]
- On-site participation (Archive streaming is not included)
- Live streaming participation (Archive streaming is not included)
- Archive streaming participation
* Those participating on-site or via live streaming can add archive streaming at a special price of 18,500 yen (tax included).
[Tuition Fee]
1 person: 37,320 yen (tax included)
Bonus: For each attendee, one person from the same corporation can accompany them for free (registration required)
* For those belonging to local governments: up to 2 people for 11,000 yen (tax included / limited to on-site and live streaming)
[Details and Registration]
https://www.jpi.co.jp/seminar/17693
- After the seminar ends, we also accept questions for the lecturer and can act as an intermediary.
- It is highly useful for building human networks among lecturers and attendees, and for creating new businesses.
- Applications for archive streaming will be accepted even after the seminar has ended.
[Contact]
Japan Planning Institute Inc.
Kowa Hiroo Bldg., 5-2-32 Minamiazabu, Minato-ku, Tokyo 106-0047
TEL. 03-5793-9761
FAX. 03-5793-9767
URL: https://www.jpi.co.jp
[About JPI (Japan Planning Institute)]
As a "bridge of knowledge connecting politics, bureaucracy, and the private sector," we support the widespread application of national policies and national projects, and have been providing information useful for the business execution of executives and senior managers aiming to create national knowledge in the form of realistic seminars limited to attendees for half a century.